Neuphoria Therapeutics Inc. (NEUP) KPIs and segments

NEUPNasdaqPharmaceutical PreparationsFiscal year ends June 30

Financials through Q4 FY2026, quarter ended Jun 30, 2026Last filing: 10-K on Sep 18, 2026Score 5/30

$2.55−0.03 (-1.16%)

Close on Nov 13, 2026Market cap $76.66KP/E –Yield –

KPIs & segments

Operating metrics and segments that drive Neuphoria Therapeutics's business

Coming soon

This tab will track the numbers specific to Neuphoria Therapeutics's business model — such as store count, revenue by banner, revenue per store and new openings — taken from filings and earnings releases.

See a number that looks wrong?